CD94/NKG2A is an inhibitory receptor expressed by natural killer (NK) cells and a subset of CD8 þ T cells. Ligation of CD94/ NKG2A by its ligand HLA-E results in tyrosine phosphorylation of the NKG2A immunoreceptor tyrosine-based inhibitory motifs, and recruitment and activation of the SH2 domain-bearing tyrosine phosphatase-1, which in turn suppresses activation signals. The nkg2a gene encodes two isoforms, NKG2A and NKG2B, with the latter lacking the stem region. We identified three new alternative transcripts of the cd94 gene in addition to the originally described canonical CD94 Full . One of the transcripts, termed CD94-T4, lacks the portion that encodes the stem region. CD94-T4 associates with both NKG2A and NKG2B, but preferentially associates with the latter. This is probably due to the absence of a stem region in both CD94-T4 and NKG2B. CD94-T4/NKG2B is capable of binding HLA-E and, when expressed in E6-1 Jurkat T cells, inhibits TCR mediated signals, demonstrating that this heterodimer is functional. Coevolution of stemless isoforms of CD94 and NKG2A that preferentially pair with each other to produce a functional heterodimer indicates that this may be more than a serendipitous event. CD94-T4/NKG2B may contribute to the plasticity of the NK immunological synapse by insuring an adequate inhibitory signal.
Introduction
Natural killer (NK) cells are members of the innate immune system, which express a wide variety of activation receptors that allow them to recognize potential target cells, such as virally infected and tumorigenic cells, without prior sensitization. 1, 2 The consequences of NK cell activation are target cell lysis and/or the production of inflammatory cytokines, such as tumor necrosis factor (TNF)-a and interferon (IFN)-g. 3 Many ligands recognized by NK cell activation receptors are proteins expressed by normal cells, which poses an obvious danger to the host. [3] [4] [5] In order to prevent unwanted responses to normal cells, NK cells also express inhibitory receptors, many of which recognize major histocompatibilty complex (MHC) class I molecules that are expressed by most normal cells. [6] [7] [8] In general, inhibitory signals override activation signals by recruiting protein tyrosine phosphatases to the proximity of signal initiation. 9, 10 The interaction of MHC class I molecules with inhibitory receptors plays a primary role in protecting normal cells from the deleterious effects of NK cell recognition. Once the expression of class I molecules is downregulated, as is often the case with viral infection or malignant transformation, cells become vulnerable to NK cell mediated lysis. [3] [4] [5] In humans, the inhibitory receptors expressed by NK cells that interact with MHC class I molecules include members of the Ig superfamily, killer cell Ig-like receptors (KIR) and Ig-like transcripts (ILT), and the CD94/NKG2A heterodimer composed of the covalently associated C-type lectin-like proteins CD94 and NKG2A. 6, 11 CD94/NKG2A is expressed on the vast majority of human NK cells and by some CD8 þ T cells. 6 Its ligand is the nonclassical class I molecule human leukocyte antigen (HLA)-E. [12] [13] [14] Cell surface expression of the CD94/NKG2A receptor is controlled both at the transcriptional and post-transcriptional levels. [15] [16] [17] [18] CD94 can also form activating receptors when paired with NKG2C or NKG2E. 6 Previous work has identified functional isoforms of NKG2A and NKG2E, known as NKG2B and NKG2H, respectively, that are generated by alternative splicing of the relevant pre-mRNAs. 19, 20 Although alternative transcripts for CD94 have been reported, 21 it has not been shown if they can be translated, and if so, if they are capable of forming functional receptors with NKG2 family members. One of the previously reported CD94 transcripts, CD94-T2, lacks the 93 bp region corresponding to exon 2 and codes for a protein lacking the transmembrane domain. 21 CD94B, which has been reported to Genbank but is not described in any primary literature, is generated by the use of an alternative splice site within intron 4. This results in the insertion of three base pairs at the beginning of exon 5 that encode a glutamine residue within the carbohydrate recognition domain (CRD). The recently discovered CD94C contains an untranslated exon 1A at the beginning of the transcript, which is not found in the canonical CD94 transcript. 17 Here, we identify three new alternative transcripts, CD94-T3, CD94-T4 and CD94B-T2, which are expressed by the NKL cell line and freshly isolated NK cells. We show that CD94-T2, -T3 and -T4 can be expressed as proteins and that the CD94-T4 protein forms functional heterodimers with NKG2A or NKG2B, with a preference for the latter. These findings suggest that CD94-T4/NKG2B is the result of coselection for alternative spliced gene products, which may be indicative of a functional significance.
Results
The CD94 gene produces multiple alternatively spliced transcripts CD94 transcripts were amplified using RT-PCR, which was performed on total RNA isolated from NKL cells. The products were subsequently cloned and sequenced. In addition to the previously described canonical CD94 (CD94 Full ) and CD94-T2 transcripts, 21, 22 three new transcripts were identified. An 802 bp transcript termed CD94-T3 (Accession Number AF498040), a 789 bp transcript termed CD94-T4 (Accession number AY327501) and a 703 bp transcript termed CD94B-T2 (Accession number AF498041).
Examination of the coding sequence of the alternative transcripts revealed that each of them lacked sequence of a full or partial exon that is present in the CD94 Full transcript (Figure 1 ). An alternative splice site within exon 5 resulted in CD94-T3, which lacks the first 51 bp of exon 5. The removal of this sequence causes a frameshift and generates a premature stop codon immediately after this novel acceptor site. The truncated sequence codes for a protein lacking much of the extracellular CRD ( Figure 1a) . The predicted protein encoded by the CD94-T3 transcript retains both the transmembrane domain and the cysteine (C58) that participates in the interchain bond between the full-length CD94 and members of the NKG2 family (Figure 1b) . 23, 24 This suggests that it could be expressed on the cell surface and pair with NKG2 family members. In contrast, the 703 bp CD94B-T2 transcript does not appear to encode a partner for NKG2 proteins since it does not encode C58 or any part of the CRD. In the CD94B-T2 transcript, a frameshift occurs after exon 3 that leads to the reading of a premature stop codon in exon 5, which is preceded by a segment coding for eighteen amino acids without homology to the CD94 Full transcript. The CD94B-T2 transcript also lacks the region encoded by most of exon 4 (152 bp) and utilizes an alternative donor splice site also used in the CD94B variant, which results in the insertion of the last three bases of intron 4 into the transcript.
The CD94-T4 transcript lacks exon 3, which is 63 bp long and codes for the stem region immediately adjacent to the CRD. Consequently, 21 amino acids would be missing from the stem region but the normal reading frame would be maintained throughout the remainder of the putative protein sequence. Since the protein encoded by CD94-T4 retains C58, this protein is predicted to be capable of interacting with NKG2A or -B. Examination of CD94 expression in fresh primary NK cells revealed that they express all of the alternatively spliced transcripts that were identified in the NKL cell line (Figure 2 ). 
Expression of alternatively spliced forms of CD94
The CD94 Full transcript, T2, T3 and T4 were expressed as FLAG-tagged fusion constructs in the YT-Indy cell line and analyzed for total protein and cell surface expression. Expression of CD94B and CD94B-T2 were not analyzed further. The YT-Indy cell line was used because it expresses NKG2A and -B but not CD94 transcripts, and therefore lacks expression of the heterodimer CD94/ NKG2A. 11 All of the fusion constructs could be expressed in YT-Indy, but only CD94 Full and CD94-T4 were capable of associating with NKG2A/B, as detected by coimmunoprecipitation (Figure 3a) . The multiple bands observed in total cell lysates after blotting with anti-FLAG monoclonal antibody (mAb) are consistent with previously reported results for the CD94 glycoprotein. 25 The anti-NKG2A antibody (clone Z199) used for the coimmunoprecipitation does not differentiate between NKG2A and NKG2B. The coimmunoprecipitation results were supported by flow cytometric analyses. CD94-T2 and T3 were not expressed on the surface of YT-Indy cells as detected indirectly by anti-NKG2A (Figure 3b ) or directly by anti-CD94 staining (data not shown). These results are not surprising, as CD94-T2 does not code for a transmembrane domain, and CD94-T3 codes for a truncated protein lacking the majority of the CRD domain, apparently preventing it from forming heterodimers with NKG2A or NKG2B and from being expressed on the cell surface. CD94-T4 was clearly detectable on the cell surface. Confocal microscopic examination of YT-Indy cells transfected with individual CD94-FLAG constructs and stained with FITC labeled anti-FLAG showed that all of the constructs were expressed intracellularly, but in agreement with the flow cytometric analysis, only the canonical CD94 Full isoforms were detected on the cell surface (Figure 3c) . Thus, CD94-T4 can associate with NKG2A and/or -B and can be expressed on the cell surface.
CD94-T4 is functional and associates preferentially with NKG2B
In comparison to the CD94 Full protein, the protein encoded by CD94-T4 lacks a stem region, which connects the CRD to the trans-membrane domain. Similarly, NKG2B also lacks a stem region in comparison to NKG2A. NKG2B is known to dimerize with CD94 and the heterodimer recognizes HLA-E.
13 CD94 Full -FLAG or CD94-T4-FLAG constructs were transiently transfected into the Jurkat E6-1 T cell line with either NKG2A or NKG2B expression vectors. We chose the Jurkat E6-1 T cell line for these experiments because it lacks endogenous CD94 and NKG2A expression. Flow cytometry analyses showed that CD94 Full had higher surface expression when expressed with NKG2A than when expressed with NKG2B ( Figure 4 , upper panels). In contrast, greater surface expression of CD94-T4 was detected when it was expressed with NKG2B. In addition to that, the intensity of the expression, as measured by the mean fluorescence intensity (MFI), was higher in cells expressing CD94 Full /NKG2A than in cells expressing CD94 Full /NKG2B, and likewise, cells expressing CD94-T4/NKG2B had higher MFIs compared to cells expressing CD94-T4/NKG2A (Figure 4 , lower panels). This suggests that full-length CD94 preferentially associates with NKG2A and that CD94-T4 favors NKG2B.
Next, we determined if the heterodimer CD94-T4/ NKG2B binds HLA-E and is able to transmit inhibitory signals. To do that, stably transfected Jurkat E6-1 T cells expressing CD94-T4/NKG2B were generated. The NK cell line NKL was used as positive control for binding HLA-E and untransfected Jurkat E6-1 cells as negative control. In Figure 5a , we show that both NKL and Jurkat E6-1 cells transfected with CD94-T4/NKG2B can bind the tetramer HLA-E-0101/VMAPRTLFL. The intensity of the tetramer binding was proportional to the cell surface expression of the receptor as measured by the binding of anti-NKG2A mAb. HLA-E-0101/SQAPLPCVL, which does not bind CD94/NKG2A, was used as a control tetramer.
14 Next, we determined the inhibitory capacity of CD94-T4/NKG2B in a luciferase reporter gene experiment. Jurkat E6-1 cells expressing CD94-T4/ NKG2B were transiently transfected with the pNFATLuc plasmid. Cells were activated with anti-CD3 þ anti-CD28 þ anti-NKG2A/B mAb or with anti-CD3 þ anti-CD28 þ isotype control mAb. Results in Figure 5b show that when anti-CD3 and anti-CD28 mAb were coligated with anti-NKG2A/B mAb, there was a 30% decrease in the reporter activity, indicating that CD94-T4/NKG2B inhibits activating signals that emanate from CD3 þ CD28 receptors.
Discussion
We have identified three new alternative transcripts of CD94 that contain changes in their coding region. The Multiple transcripts of CD94 LD Lieto et al transcripts were studied to determine if they encode proteins of potential functional consequence. Only the CD94-T4 transcript encodes a protein capable of association with NKG2A or -B, and expression on the cell surface. CD94-T2 and CD94-T3 could only be expressed intracellularly as FLAG fusion proteins and could not associate with NKG2A/B, as observed by coimmunoprecipitation analyses. This indicates that CD94 proteins lacking the transmembrane region or full-length CRD have difficulty in dimerizing with NKG2A or -B. Since there are no CD94 antibodies available that can discriminate among these isoforms, it is not possible to determine if any of these alternatively spliced CD94 transcripts are translated in normal NK cells. The exact role played by the stem region in the formation of a functional CD94 protein is somewhat unclear. The CD94 Full transcript encodes the full-length CD94 protein; CD94-T4 lacks exon 3 and produces a protein, which lacks the stem region. Both CD94 Full and CD94-T4 proteins dimerize with NKG2A and/or B (Figures 3 and 4) . It was previously described that a truncated CD94 protein, expressed in bacteria, lacking the stem region, yet retaining C58, had a lower tendency to form homodimers than CD94 Full , suggesting an important role for the stem region in the homodimerization of CD94. 23 However, our studies clearly show that stemless CD94 protein is capable of dimerizing with the products of the nkg2a gene. In the case of CD94 Full , the stem region is relatively negatively charged and corresponds to a positively charged stem region in the NKG2A protein, suggesting that complementary charged stem regions facilitate interactions between CD94 Full and NKG2A proteins. This is consistent with the observed preferential cell surface expression of CD94 Full /NKG2A heterodimers compared to CD94 Full / NKG2B heterodimers ( Figure 4) . Likewise, preferential surface expression is also seen when both molecules lack the stem region, that is CD94-T4/NKG2B, compared to heterodimers in which the stem region is present in only one partner, as with CD94-T4/NKG2A. These results indicate that the formation of heterodimers between the CD94 isoforms and NKG2A/B favors interactions between molecules containing corresponding protein domains. Cell surface NK receptors polarize toward the site of contact with target cells and form ordered macromolecular complexes within the plasma membrane of the NK cells known as the NK cell immunological synapse (NKIS). 26, 27 There are two distinct kinds of NKIS, the activating NKIS (aNKIS) and inhibitory NKIS (iNKIS). In the aNKIS activating receptors on the surface of the NK cells polarize toward the ligand bearing target cells, and the result is the killing of the target cell. This aNKIS is a complex structure requiring ATP for formation, involvement of the cytoskeleton and lipid raft polarization. [26] [27] [28] To avoid killing of normal cells, inhibitory NK receptors are crosslinked by their ligands and form an iNKIS, which function as a distinct unit, outside lipid rafts, not requiring ATP or active involvement of the cytoskeleton. 29, 30 One such inhibitory receptor is CD94 Full /NKG2A (and potentially CD94-T4/NKG2B). We have previously described the CD94/NKG2A iNKIS, which is characterized by a decrease in the lateral mobility of the accumulated receptor and exclusion of the lipid rafts at the site of contact with HLA-E bearing target cells. 30 It has been described that at the site of both iNKIS and aNKIS, the membranes of apposing cells have alternating regions of wide and narrow height. 31 These differences in the extracellular space between NK and target cells are probably determined by the size of pairs of receptor/ ligand interactions. 31, 32 This pairing is likely due to thermodynamic processes that balance the optimization of local membrane separation against the entropy costs of segregation. This model would explain the spontaneous ATP-independent segregation of proteins observed at the iNKIS. 29, 33 The CD94-T4 protein is 21 amino acids shorter than the full-length CD94. Its preferred partner is NKG2B, which is 18 amino acids shorter than NKG2A. We speculate that the size difference of the CD94-T4/NKG2B receptor may allow it to segregate to different microdomains from the CD94 Full /NKG2A receptor, which could give more plasticity to the iNKIS. Another consequence of the shorter heterodimer CD94-T4/NKG2B is a lack of flexibility when compared with CD94 Full /NKG2A, which contains a stem region that could provide some degree of flexibility. This lack of flexibility as well as the possibility of an increased plasticity at the area of interaction between NK and target cell may affect the signaling transmission in an as of yet undetermined way, possibly by fine tuning the inhibitory signal. The CD94-T4/ NKG2B receptor may have access to microdomains not accessible to the larger CD94 Full /NKG2A receptor, insuring that the inhibitory signal is present throughout the immunological synapse. A recent publication supports this hypothesis. In this case, it was shown that Tcell receptor signaling but not ligation is critically dependent on the overall size of the interacting ligands and that size based segregation of TCR-MHC complexes is important for maximal signaling. 34 It was argued that receptor-ligand dimensions are likely to be very important for receptor-ligand systems that depend on tyrosine phosphorylation of their cytoplasmic tail by tyrosine kinases, 35 as is the case for the CD94/NKG2A, -B receptors after interaction with their ligand HLA-E.
In conclusion, we show new alternative splice gene products of the human cd94 transcript. More interestingly, we describe a new heterodimer, composed of CD94-T4 and NKG2B that is capable of transmitting an inhibitory signal. The contribution of this heterodimer to the NK cell function in comparison with CD94 Full / NKG2A deserves future studies. However, the lack of specific antibodies that can distinguish between the different heterodimers makes these studies very difficult to conduct. Expression of these receptors in heterologous systems may be an approach that could help to explain the role of this inhibitory receptor in the formation of the iNKIS.
Materials and methods

Cells, plasmids, tetramers and antibodies
Polyclonal NK cells were isolated by negative selection from peripheral blood using the NK cell isolation kit (Miltenyi Biotec, Auburn, CA, USA). The purity of the isolated cell populations was confirmed by flow cytometry. NK cells were cultured in IMDM (BioWhittaker, Walkersville, MD, USA) supplemented with 500 U/ml of rIL-2 (Biological Resources Branch, National Cancer InstituteFrederick Cancer Research and Development Center, Frederick, MD, USA), 10% human AB serum (BioWhittaker), and L-glutamine (BioSource International, Rockville, MD, USA) at 371C under an atmosphere of 5% CO 2 . The NKL cell line was grown in RPMI 1640 (BioSource International) supplemented with 2 mM L-glutamine, 1 mM sodium pyruvate, 200 U/ml of rIL-2, 5 mg/ml of Plasmocin (Invivogen, San Diego, CA, USA) and 10% FBS at 371C under an atmosphere of 5% CO 2 . The YT-Indy and the Jurkat E6-1 cell lines were grown in RPMI 1640 supplemented with 2 mM L-glutamine, 10 mM nonessential amino acids, 5 mg/ml of Plasmocin and 10% FBS.
CD94-FLAG fusion proteins were expressed by cloning CD94 cDNAs into the BamHI/EcoRI sites of p3 Â FLAG-CMV-10 (Sigma-Aldrich, St Louis, MO, USA). In these proteins, the FLAG domains are attached to the N terminus of these type II transmembrane proteins. NKG2A and NKG2B were expressed by cloning into the KpnI/XhoI sites of pcdna3.1-Neo þ (Invitrogen, Carlsbad, CA, USA). YT-Indy cells were transfected as previously described 17 and 2 Â 10 6 Jurkat E6-1 cells were transiently transfected by electroporation with 1.25 mg/10 6 cells of a CD94-FLAG construct and 1.25 mg/10 6 cells of the NKG2A or NKG2B construct. pNFAT-Luc plasmid is from Stratagene (La Jolla, CA, USA) and the Renilla plasmid from Promega (Madison, WI, USA). We used two HLA-E tetramers provided by the NIAID tetramer core facility (Atlanta, GA, USA). The tetramer HLA-E-0101/VMAPRTLFL binds both CD94/NKG2A and CD94/NKG2C 36 while the tetramer HLA-E-0101/ SQAPLPCVL does not.
14 Sources for each antibody (Ab) are indicated: anti-NKG2A/B mAb (Z199, IgG2b), anti-CD94 mAb (HP-3B1, IgG2a) with and without PE conjugation from Beckman Coulter (Fullerton, CA, USA); anti-CD3 mAb (UCHT1, IgG1), anti-CD28 (clone CD28.2, IgG1), unlabeled and PE-conjugated isotypematched control Ab IgG2b, isotype matched for Z199, were purchased from BD PharMingen (San Diego, CA, USA); anti-FLAG peroxidase conjugate (M2) with and without FITC conjugation from Sigma-Aldrich and antimouse IgG (H&L) from Jackson ImmunoResearch Laboratories (West Grove, PA, USA). Flow cytometric analyses were performed on a FACSort cytofluorometer (BD Biosciences, San Jose, CA, USA). Results were analyzed by CellQuest (BD Biosciences) and FlowJo 6.3.1 software package (Treestar, San Carlos, CA, USA).
RNA Isolation, RT-PCR and sequence analyses Total RNA was prepared from fresh primary NK, or cultured NKL cells using the RNAqueous Midi kit (Ambion, Austin, TX, USA). RNA concentration was estimated by spectrophotometric analysis. RT-PCR was performed using transcript specific primers and the Superscript One-Step RT-PCR kit (Invitrogen, Carlsbad, CA, USA). The expression of CD94 transcripts as well as b-actin transcripts as an internal control was determined using 250 ng of cDNA. The following primers were used: CD94-Exon 1A-5
0 . PCR products were visualized by electrophoresis on 1 Â TBE, 1% agarose gels and stained with ethidium bromide. cDNA was ligated into the pCR2.1 vector using the TA cloning kit from Invitrogen. The ligation products were used to transform Top10F cells, which were plated on LB agar plates supplemented with 100 mg/ml ampicillin (KD Medical, Columbia, MD, USA). Single colonies were selected, DNA was isolated and PCR amplified using the primer sets described above. Amplification products were isolated and labeled using Big Dye kit v3.0 terminators (Applied Biosystems, Foster City, CA, USA). Sequence analysis was performed by MWG Biotech (Highpoint, NC, USA). Sequences were aligned with the CD94 Full transcript using the Blast algorithm from NCBI (http:// www.ncbi.nlm.nih.gov/BLAST/). Amino-acid sequences were aligned using Omega 2.0 (Oxford Molecular, Oxford, UK).
Immunoprecipitation and immunoblotting
YT-Indy cells (4 Â 10 6 ) were transfected with each CD94-FLAG construct and incubated overnight at 371C in complete media. After washing with PBS, cells were lysed in 1 ml of lysis buffer (PBS with 0.5% NP-40, and protease inhibitor mixture for mammalian cell extracts (Sigma-Aldrich)). After 30 min on ice, lysates were cleared of debris by centrifugation at 16 000 g for 15 min at 41C. Immunoprecipitations were carried out with anti-NKG2A mAb (clone Z199) preattached to protein A magnetic beads (Dynal Biotech, Lake Success, NY, USA), according to the manufacturer's protocol. Immunoprecipitates and whole-cell lysates were boiled for 5 min in reducing sample buffer (50 mM Tris-Cl (pH 6.8), 2% (w/ v) SDS, 0.1% (w/v) bromphenol blue, 10% (v/v) glycerol, and 100 mM 2-ME). Samples were then fractionated by SDS-PAGE (10% acrylamide) and transferred onto Immobilon-PVDF membranes (Millipore, Bedford, MA, USA). Membranes were then blocked with 5% (w/v) milk and 0.05% Tween-20 in PBS for 1 h and then probed with peroxidase-conjugated anti-FLAG M2 in PBS with 0.05% Tween-20 for 16 h at 41C. Membranes were washed 6 Â for 5 min each in PBS with 0.05% Tween-20. The peroxidase-labeled Ab was detected using an ECL Western blotting kit (Amersham Pharmacia Biotech, Piscataway, NJ, USA).
Confocal microscopic studies YT-Indy cells were transfected with CD94-FLAG constructs and incubated overnight. The cells were pelleted, washed twice with PBS and spotted on polylysine slides (Sigma Diagnostics, St Louis, MO, USA). Cells were permeabilized using the Intraprep Permeabilization Kit (Beckman Coulter), following the manufacturer's protocols. Cells were stained with FITC conjugated anti-FLAG M2 (Sigma Aldrich), 2 mg in 500 ml of PBS for 15 min. Cells were washed twice with PBS, once with 0.5% paraformaldehyde in PBS and mounted with Vectashield mounting medium from Vector Laboratories (Burlingame, CA, USA). Images were collected on a Leica TCS-SP2 confocal microscope (Leica Microsystems, Exton, PA, USA) equipped with argon (488 nm) and krypton (568 nm) lasers, using a Â 63 oil immersion objective NA 1.25. Detector slits were adjusted to minimize overlap between the channels. Images were processed with Imaris software v3.1.2 (Bitplane, Zurich, Switzerland) without filtering.
Luciferase reporter assay and CD94-T4/NKG2B stable transfectants Jurkat E6-1 cells were stably transfected with the CD94-T4-FLAG and NKG2B plasmids and grown in medium containing Geneticin (Invitrogen) at 1 mg/ml and Hygromycin B (Invitrogen) at 0.6 mg/ml. These stably transfected cells were used for subsequent luciferase reporter assays. Briefly, CD94-T4/NKG2B Jurkat E6-1 cells were electroporated with 5 mg of pNFAT-Luc plasmid and 0.25 mg of Renilla plasmid using kit V and program O-17 from Amaxa Inc. (Gaithersburg, MD, USA) following the manufacturer's instructions. After 24 h of incubation at 371C, cells were washed and resuspended in fresh medium at a concentration of 0.5-1 Â 10 6 cells/ml. Cells (1 ml) was transferred to microfuge tubes and 1 mg of anti-CD3, and 20 mg of anti-CD28, anti-NKG2A (clone Z199) and/or control IgG2b (clone MPC-11; BD Pharmingen) were added, followed by 15 min of incubation on ice. After centrifugation of cells, supernatant was removed and 1 ml of fresh medium containing 40 mg of GAM for crosslinking of the primary mAb was added. Then, cells were incubated on ice for 10 min, pelleted and resuspended in 1 ml of fresh medium and transferred onto 24-well plates. After 20 h of incubation at 371C, cells were harvested and lysed. Luciferase and Renillase activities were measured with a Monolight 3010 Luminometer (Analytical Luminescence Laboratory).
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